Fate after pulmonary administration
Devenir des nanoparticules utilisées comme médicament dans l'organisme

Add to my library

MED5050 V1 Archive

Fate after pulmonary administration


Devenir des nanoparticules utilisées comme médicament dans l'organisme

Author : Frédéric LAGARCE

Publication date: October 10, 2014 | Lire en français

Add to my library Add to my library

Logo Techniques de l'Ingenieur You do not have access to this resource.
Request your free trial access! Free trial

Already subscribed?

5. Fate after pulmonary administration

5.1 Lung physiology

The role of the lung is to oxygenate the blood by bringing oxygen from the air and eliminating carbon dioxide. The channels carrying these gases are the bronchi and bronchioles. The pulmonary tree comprises 23 bifurcations, leading from the larger bronchi to the bronchioles and on to the pulmonary alveoli, where gas exchange takes place. At the proximal level, the epithelium is pseudostratified and composed of waxy cells and mucus-secreting caliciform cells. The epithelium then thins to become very thin at the level of the pulmonary alveoli. It is then composed of two cell types: type I pneumocytes (95% of cells) and type II pneumocytes, which produce surfactant and are the precursors of type I pneumocytes. Surfactant is a substance that forms a film over the alveoli,...

You do not have access to this resource.
Logo Techniques de l'Ingenieur

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed?


Ongoing reading
Fate after pulmonary administration

Article included in this offer

"Nanosciences and nanotechnologies"

( 139 articles )

Complete knowledge base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

View offer details

Contenus associés

Sur le même sujet

Veille personnalisée : Inscrivez-vous !
Contact us